MicroRNA-126 acts as a tumor suppressor in glioma cells by targeting insulin receptor substrate 1 (IRS-1) [Retraction].

IF 1.1 Q4 ONCOLOGY

International journal of clinical and experimental pathology Pub Date : 2022-08-15 eCollection Date: 2022-01-01

引用次数: 0

Abstract

[This retracts the article on p. 10345 in vol. 8, PMID: 26617742.].

本刊更多论文

MicroRNA-126通过靶向胰岛素受体底物1 (IRS-1)在胶质瘤细胞中起肿瘤抑制作用[撤回]。

[本文撤回了第8卷第10345页的文章，PMID: 26617742]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of clinical and experimental pathology ONCOLOGY-PATHOLOGY

自引率

0.00%

发文量

审稿时长

1 months

期刊介绍： The International Journal of Clinical and Experimental Pathology (IJCEP, ISSN 1936-2625) is a peer reviewed, open access online journal. It was founded in 2008 by an international group of academic pathologists and scientists who are devoted to the scientific exploration of human disease and the rapid dissemination of original data. Unlike most other open access online journals, IJCEP will keep all the traditional features of paper print that we are all familiar with, such as continuous volume and issue numbers, as well as continuous page numbers to keep our warm feelings towards an academic journal. Unlike most other open access online journals, IJCEP will keep all the traditional features of paper print that we are all familiar with, such as continuous volume and issue numbers, as well as continuous page numbers to keep our warm feelings towards an academic journal.